Skip to main content

Research Repository

Advanced Search

Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs

Bertero, Alessandro; Pawlowski, Matthias; Ortmann, Daniel; Snijders, Kirsten; Yiangou, Loukia; Cardoso de Brito, Miguel; Brown, Stephanie; Bernard, William G.; Cooper, James D.; Giacomelli, Elisa; Gambardella, Laure; Hannan, Nicholas R.F.; Iyer, Dharini; Sampaziotis, Fotios; Serrano, Felipe; Zonneveld, Mari�lle C.F.; Sinha, Sanjay; Kotter, Mark; Vallier, Ludovic

Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs Thumbnail


Authors

Alessandro Bertero

Matthias Pawlowski

Daniel Ortmann

Kirsten Snijders

Loukia Yiangou

Miguel Cardoso de Brito

Stephanie Brown

William G. Bernard

James D. Cooper

Elisa Giacomelli

Laure Gambardella

NICK HANNAN NICK.HANNAN@NOTTINGHAM.AC.UK
Associate Professor

Dharini Iyer

Fotios Sampaziotis

Felipe Serrano

Mari�lle C.F. Zonneveld

Sanjay Sinha

Mark Kotter

Ludovic Vallier



Abstract

© 2016. Inducible loss of gene function experiments are necessary to uncover mechanisms underlying development, physiology and disease. However, current methods are complex, lack robustness and do not work in multiple cell types. Here we address these limitations by developing single-step optimized inducible gene knockdown or knockout (sOPTiKD or sOPTiKO) platforms. These are based on genetic engineering of human genomic safe harbors combined with an improved tetracycline-inducible system and CRISPR/Cas9 technology. We exemplify the efficacy of these methods in human pluripotent stem cells (hPSCs), and show that generation of sOPTiKD/KO hPSCs is simple, rapid and allows tightly controlled individual or multiplexed gene knockdown or knockout in hPSCs and in a wide variety of differentiated cells. Finally, we illustrate the general applicability of this approach by investigating the function of transcription factors (OCT4 and T), cell cycle regulators (cyclin D family members) and epigenetic modifiers (DPY30). Overall, sOPTiKD and sOPTiKO provide a unique opportunity for functional analyses in multiple cell types relevant for the study of human development.

Citation

Bertero, A., Pawlowski, M., Ortmann, D., Snijders, K., Yiangou, L., Cardoso de Brito, M., …Vallier, L. (2016). Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs. Development, 143(23), 4405-4418. https://doi.org/10.1242/dev.138081

Journal Article Type Article
Acceptance Date Oct 7, 2016
Online Publication Date Nov 29, 2016
Publication Date Dec 1, 2016
Deposit Date May 23, 2017
Publicly Available Date May 23, 2017
Journal Development
Print ISSN 0950-1991
Electronic ISSN 1477-9129
Publisher Company of Biologists
Peer Reviewed Peer Reviewed
Volume 143
Issue 23
Pages 4405-4418
DOI https://doi.org/10.1242/dev.138081
Keywords Human pluripotent stem cells, shRNA, CRISPR/Cas9,
OCT4, POU5F1, T, brachyury, DPY30
Public URL https://nottingham-repository.worktribe.com/output/825170
Publisher URL http://dev.biologists.org/content/143/23/4405
Contract Date May 23, 2017

Files





You might also like



Downloadable Citations